Liquidia (LQDA) Other financing activities (2020 - 2026)
Liquidia (LQDA) posted quarterly Other financing activities of $1.8 million for Q1 2026, up 38.61% year-over-year from $1.3 million in Q1 2025, and up 87.38% quarter-over-quarter from $935000.0 in Q4 2025.
Liquidia (LQDA) Other financing activities (2020 - 2026) Analysis & Trends
Liquidia's Other financing activities history runs 7 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- In Q1 2026, Other financing activities rose 38.61% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $5.3 million (down 96.19% YoY), while the FY2025 annual figure was $4.8 million, down 96.52% from the prior year.
- Other financing activities for Q1 2026 stood at $1.8 million, up from $935000.0 in the prior quarter.
- The five-year high for Other financing activities was $135.6 million in Q4 2024, with the low at -$71.9 million in Q3 2024.
- The 5-year median for Other financing activities is $621000.0 (2022), against an average of $8.7 million.
- The sharpest annual moves came in 2022 and 2024: Other financing activities tumbled 133512.5% in 2022, then soared 232290.62% in 2024.
- Liquidia's Other financing activities stood at -$53.4 million in 2022, then jumped by 100.15% to $80000.0 in 2023, then jumped by 169428.75% to $135.6 million in 2024, then plunged by 99.31% to $935000.0 in 2025, then surged by 87.38% to $1.8 million in 2026.
- Business Quant data shows LQDA's Other financing activities at $1.8 million in Q1 2026, $935000.0 in Q4 2025, and $2.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Liquidia | 6.34 Bn | 6.05 Bn | 160.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.44 Mn |
| Jun 30, 2026 | 1.44 Mn |
| Mar 31, 2026 | 1.75 Mn |
| Mar 31, 2026 | 1.75 Mn |
| Dec 31, 2025 | 935,000.00 |
| Dec 31, 2025 | 935,000.00 |
| Sep 30, 2025 | 2.50 Mn |
| Sep 30, 2025 | 2.50 Mn |
| Jun 30, 2025 | 125,000.00 |
| Jun 30, 2025 | 125,000.00 |
| Mar 31, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 135.62 Mn |
| Dec 31, 2024 | 135.62 Mn |
| Sep 30, 2024 | -71.94 Mn |
| Sep 30, 2024 | -71.94 Mn |
| Jun 30, 2024 | 74.37 Mn |
| Jun 30, 2024 | 74.37 Mn |
| Mar 31, 2024 | 503,000.00 |
| Mar 31, 2024 | 503,000.00 |